Product image of Cluvot (Human Coagulation Factor Xiii) supplied by GNH India

Cluvot

Active Ingredient:
Human Coagulation Factor Xiii
Origin:
EU

Cluvot (Human Coagulation Factor Xiii)

Cluvot is a pharmaceutical product containing Human Coagulation Factor XIII, used to support blood clotting. This intravenous medication is manufactured by CSL Behring GmbH and is suitable for patients with specific clotting disorders.

Manufacturer / TM Owner

Csl Behring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Cluvot is primarily used to manage conditions related to coagulation disorders. Human Coagulation Factor XIII plays a crucial role in the final stages of blood clotting, making this medication essential for individuals who require support in this process. It is often prescribed for conditions where the body's natural clotting mechanisms are insufficient.

Side Effects

  • Cluvot works by enhancing the body's ability to form stable blood clots. This can help prevent excessive bleeding in individuals with coagulation disorders. The effects of Cluvot are typically observed through improved clotting times and reduced bleeding episodes.

Precautions & Warnings

  • Cluvot should be administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration guidelines to minimize the risk of adverse effects. Patients should inform their healthcare provider about any allergies or medical conditions before using Cluvot.

Avoid Interactions

  • Cluvot may interact with other medications that affect blood clotting. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, patients should be cautious when using Cluvot in conjunction with other blood-thinning or clotting agents.

Frequently Asked Questions

Cluvot is used to support blood clotting in individuals with coagulation disorders.

Cluvot is administered intravenously under the supervision of a healthcare professional.

Cluvot enhances the body's ability to form stable blood clots, which can help prevent excessive bleeding.

Yes, Cluvot should be used under the guidance of a healthcare provider, and patients should inform their provider about any allergies or medical conditions.

Cluvot may interact with other medications that affect blood clotting, so it is important to discuss all current medications with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Xiii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT